CRXT Stock Price, News & Analysis

CRXT NASDAQ

Company Description

CRXT (NASDAQ: CRXT) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $2.5M.

CRXT stock has declined 99.4% over the past year.

This page provides a comprehensive overview of CRXT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-99.4%

Performance 1 year

$2.5M

Market Cap

0.0

Shares outstanding

CRXT (CRXT) stock. Over the past 12 months, the stock has lost 99.4%. At a market capitalization of $2.5M, CRXT is classified as a micro-cap stock.

Latest News

View All

October 18, 2022

—

Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder

September 6, 2022

-31.16%

Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

August 18, 2022

-27.19%

Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

earnings

July 28, 2022

+0.39%

Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)

June 23, 2022

-5.69%

Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer

management

June 9, 2022

-5.98%

Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting

conferences

CRXT has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 8 with negative movement. Key topics include earnings, management, conferences. View all CRXT news →

SEC Filings

View All

No SEC filings available for CRXT.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CRXT Company Profile & Sector Positioning

CRXT (CRXT) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the market cap of CRXT (CRXT)?

The market cap of CRXT (CRXT) is approximately 2.5M. Learn more about what market capitalization means .